|
Market Closed -
Nasdaq
01:00:00 21/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 96.13 USD | +0.65% |
|
+3.00% | +21.70% |
| 11-10 | Mirum Pharmaceuticals' Phase 3 Study of Chronic Hepatitis Delta Virus Treatment Meets Primary Endpoint | MT |
| 11-10 | Mirum's liver infection drug lowers virus levels in second late-stage study | RE |
| Market Cap | 6.27B 5.72B 5.27B 4.79B 8.99B 581B 9.44B 64.09B 25.47B 317B 23.54B 23.05B 996B | P/E 2026 * |
-6.35x | P/E 2027 * | -70.3x |
|---|---|---|---|---|---|
| Enterprise Value | 6.33B 5.77B 5.31B 4.83B 9.07B 586B 9.53B 64.69B 25.71B 320B 23.76B 23.26B 1,005B | EV / Sales 2026 * |
8.82x | EV / Sales 2027 * | 7.38x |
| Free-Float |
98.33% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MIRM | Delayed | |
| MIRM | Real-time | ||
| 08D | Real-time | ||
| 08D | Delayed | ||
| 08D | Real-time | ||
| 08D | Delayed | ||
| 08D | Delayed |
Last Transcript: Mirum Pharmaceuticals, Inc.
| 1 day | +0.65% | ||
| 1 week | +3.00% | ||
| Current month | +13.09% | ||
| 1 month | +16.89% | ||
| 3 months | -5.98% | ||
| 6 months | +0.50% | ||
| Current year | +21.70% |
| 1 week | 89.27 | 98.39 | |
| 1 month | 80.24 | 98.97 | |
| Current year | 73.82 | 130 | |
| 1 year | 63.23 | 130 | |
| 3 years | 23.14 | 130 | |
| 5 years | 12.82 | 130 | |
| 10 years | 6.51 | 130 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 47 | 21/03/2019 | |
Eric Bjerkholt
DFI | Director of Finance/CFO | 66 | 11/09/2023 |
Peter Radovich
PSD | President | 48 | 16/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Grey
CHM | Chairman | 73 | 21/03/2019 |
Patrick Heron
BRD | Director/Board Member | 55 | 07/11/2018 |
| Director/Board Member | 47 | 01/11/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/11/26 | Exercice | Chief Executive Officer | 60,000 | 0.0924% | ||
| 16/10/26 | Exercice | Controller/Auditor | 32,224 | 0.0496% | ||
| 09/10/26 | Free | Chief Technology Officer | 65,000 | 0.1001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.65% | +3.00% | +36.48% | +197.43% | 6.24B | ||
| -0.30% | -5.62% | +28.35% | +127.66% | 1,204B | ||
| +1.25% | -4.60% | +33.56% | +80.57% | 643B | ||
| +0.94% | -2.80% | +22.88% | +106.94% | 501B | ||
| -0.60% | -2.39% | +27.92% | +67.00% | 378B | ||
| +0.69% | -9.00% | +40.68% | +31.42% | 327B | ||
| +0.41% | -4.81% | +24.99% | +51.91% | 285B | ||
| +0.81% | -3.72% | -1.35% | +30.72% | 270B | ||
| -0.15% | -6.73% | +27.23% | +64.15% | 237B | ||
| -0.06% | -0.91% | +29.95% | +120.58% | 207B | ||
| Average | +0.40% | -3.73% | +27.07% | +87.84% | 406B | |
| Weighted average by Cap. | +0.39% | -4.70% | +27.27% | +88.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 718M 654M 602M 548M 1.03B 66.45B 1.08B 7.33B 2.91B 36.3B 2.69B 2.64B 114B | 869M 791M 729M 663M 1.24B 80.43B 1.31B 8.87B 3.53B 43.93B 3.26B 3.19B 138B |
| Net income | -939M -855M -788M -717M -1.34B -86.93B -1.41B -9.59B -3.81B -47.48B -3.52B -3.45B -149B | -100M -91.47M -84.28M -76.67M -144M -9.3B -151M -1.03B -408M -5.08B -377M -369M -15.94B |
| Net Debt | 57.92M 52.75M 48.61M 44.22M 82.95M 5.36B 87.18M 592M 235M 2.93B 217M 213M 9.19B | 135M 123M 113M 103M 193M 12.49B 203M 1.38B 547M 6.82B 506M 495M 21.4B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | $96.12 | +0.64% | 1,044,263 |
| 19/11/26 | $95.51 | +3.27% | 777,603 |
| 18/11/26 | $92.49 | +0.59% | 498,221 |
| 17/11/26 | $91.95 | +0.40% | 377,668 |
| 16/11/26 | $91.58 | -2.56% | 506,487 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- MIRM Stock
Select your edition
All financial news and data tailored to specific country editions
















